Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

GAO to examine panel on foreign investment in U.S. strategic firms

Published 10/03/2016, 01:53 PM
Updated 10/03/2016, 02:00 PM
GAO to examine panel on foreign investment in U.S. strategic firms

WASHINGTON (Reuters) - The investigative arm of Congress has agreed to examine whether a panel that oversees foreign investment in the United States has the legal powers it needs to keep up with efforts by state-owned firms in Russia and China to buy strategic U.S. companies.

The Government Accountability Office said in a letter to lawmakers released on Monday that it would begin the review in about four months once the staff with the needed expertise were cleared of other duties. The letter was dated Sept. 30.

The study is being initiated in response to a request on Sept. 15 by 16 members of Congress, who voiced concern that legislation governing the Committee on Foreign Investment in the United States (CFIUS) has not been updated enough to ensure the panel can do its job effectively.

"Now is an opportune time for GAO to review what has worked well, and where CFIUS authorities may need to be expanded, especially given the rise in state-owned enterprises and state-controlled enterprises from China and Russia, among other designated countries," the lawmakers said in their letter.

The letter from the lawmakers noted that foreign investment oversight began as an executive order from the president and was only codified by Congress in response to concerns about foreign ownership of defense industries and ports.

The letter said lawmakers were now concerned about recent investments in the telecommunications, media and agriculture sectors that raised questions about "the degree to which foreign ownership ... may pose a strategic rather than overt national security threat."

It noted that Chinese companies designated by Beijing as "state champions" often benefited from illegal subsidies in order to gain strategic access to markets like the United States.

The letter said Congress had raised concerns about China National Chemical Corp's (ChemChina) planned $43 billion acquisition of Swiss agricultural seed and pesticides provider Syngenta AG (S:SYNN) and to Dalian Wanda Group's bid for major American movie studios like Legendary Entertainment and Paramount Studios.

It said the media acquisitions were particularly concerning because of "China's efforts to censor topics and exert propaganda controls on American media."

"These examples raise serious security questions about what authority CFIUS currently has, or may need to be added, to address these concerns," the lawmakers said in their letter.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.